Long Term Follow-Up of Traumatic Fracture Patients Treated With Integrated Complementary and Alternative Medicine: Observational Study

January 25, 2022 updated by: In-Hyuk Ha, KMD, Jaseng Medical Foundation

The purpose of this study is to reveal the effectiveness of integrative Korean medicine for trauma fracture by observation inpatients treated with integrative Korean medicine.

This study is a prospective observational study. The subjects for study are patients diagnosed with fracture and who have been admitted to five Jaseng Hospital of Korean medicine (Gangnam, Bucheon, Daejeon, Bundang and Haeundae) for 2017.03-2020.08.

Medical records of selected patients will be analyzed, and online google surveys(or telephone) will be conducted for each patient. The survey questions are Numeric rating scale (NRS), quality of life, and Patient Global Impression of Change (PGIC), etc.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

665

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 85 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The subjects for study are patients diagnosed with fracture and who have been admitted to five Jaseng Hospital of Korean medicine (Gangnam, Bucheon, Daejeon, Bundang and Haeundae) for 2017.03-2020.08.

Description

Inclusion Criteria:

  1. 19-85 years old
  2. Pateints who have been admitted to five Jaseng Hospital of Korean medicine (Gangnam, Bucheon, Daejeon, Bundang and Haeundae) and hospitalized 5 days or more
  3. fracture caused by trauma
  4. Patients have agreed to participate the study.

Exclusion Criteria:

  1. pathological fracture, stress fracture
  2. Open fracture
  3. The cause of pain is due to other disease, not the fracture: tumors, fibromyalgia, rheumatoid arthritis, gout, etc.
  4. Patients who are difficult to complete the research questionaire because of communication, mental or physical capabilities.
  5. lack of data of collection
  6. Patients deemed unable to participate in the clinical research by other researchers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline Numeric rating scale(NRS) to longterm f/u survey
Time Frame: baseline(admission), week 1, 2, 3, 4, 5, 6, 7, day of Discharge(up to week 8), finish f/u survey by June 2021
NRS uses an 11-point scale to evaluate current neck pain and radiating pain where no pain is indicated by '0', and the worst pain imaginable by '10'.
baseline(admission), week 1, 2, 3, 4, 5, 6, 7, day of Discharge(up to week 8), finish f/u survey by June 2021

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The five level version of EuroQol-5 Dimension (EQ-5D)
Time Frame: baseline(admission), week 2, 4, 6, day of Discharge(up to week 8), finish f/u survey by June 2021
EQ-5D is most widely used as a method of indirectly calculating the quality of life from various aspects. The EQ-5D-5L consists of 5 questions (mobility, self-care, usual activities, pain, anxiety/depression) that ask about the current state of health, and answers each question with 5 likert. (1=I have no problems about, 2=I have slight problems about, 3=I have moderate problems about, 4=I have severe problems about, 5=I am unable to about) In this study, the validated Korean version questionnaire will be used
baseline(admission), week 2, 4, 6, day of Discharge(up to week 8), finish f/u survey by June 2021
Oswestry disability index (ODI)
Time Frame: baseline(admission), week 2, 4, 6, day of Discharge(up to week 8), finish f/u survey by June 2021
The ODI is a 10-item questionnaire developed to evaluate the degree of disability for low back pain. Each item is divided into 6 levels, and 0 to 5 points are awarded. The higher the score, the greater the degree of disability. We will conduct an validated Korean ODI questionnaire(to L-SPINE, T-SPINE and sacrum fracture)
baseline(admission), week 2, 4, 6, day of Discharge(up to week 8), finish f/u survey by June 2021
Neck Disability Index (NDI)
Time Frame: baseline(admission), week 2, 4, 6, day of Discharge(up to week 8), finish f/u survey by June 2021
NDI is a 10-item questionnaire developed to evaluate the degree of disability for neck back pain. Each item is divided into 6 levels, and 0 to 5 points are awarded. The higher the score, the greater the degree of disability. We will conduct an validated Korean NDI questionnaire (to C-SPINE fracture)
baseline(admission), week 2, 4, 6, day of Discharge(up to week 8), finish f/u survey by June 2021
Shoulder Pain and Disability Index (SPADI)
Time Frame: baseline(admission), week 2, 4, 6, day of Discharge(up to week 8), finish f/u survey by June 2021
The Shoulder Pain and Disability Index (SPADI) is a patient completed questionnaire with 13 items assessing pain level and extent of difficulty with ADLs requiring the use of the upper extremities. The pain subscale has 5-items and the Disability subscale has 8-items. We will conduct an validated Korean SPADI questionnaire (to shoulder fracture)
baseline(admission), week 2, 4, 6, day of Discharge(up to week 8), finish f/u survey by June 2021
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Time Frame: baseline(admission), week 2, 4, 6, day of Discharge(up to week 8), finish f/u survey by June 2021
WOMAC is a widely used, proprietary set of standardized questionnaires used by health professionals to evaluate the condition of patients with osteoarthritis of the knee and hip, including pain, stiffness, and physical functioning of the joints. The WOMAC measures five items for pain (score range 0-20), two for stiffness (score range 0-8), and 17 for functional limitation (score range 0-68). We will conduct an validated Korean WOMAC questionnaire. (to knee fracture)
baseline(admission), week 2, 4, 6, day of Discharge(up to week 8), finish f/u survey by June 2021
Quick Disabilities of the Arm, Shoulder, and Hand questionnaire (QuickDASH)
Time Frame: at finish f/u survey by June 2021
The DASH, an instrument that evaluates upper ex- tremity disabilities, has advantages for analyzing the overall function of the upper extremity. The 30 items in the questionnaire ask about different upper extremity disabilities in terms of symptoms, physical functions, social functions, and psychological problems. A shorter version of DASH, known as Quick Disabilities of the Arm, Shoulder, and Hand questionnaire (QuickDASH), consists of 11 items from the original DASH. We will conduct an validated Korean Quick DASH questionnaire. (to clavicle, arm and hand fracture)
at finish f/u survey by June 2021
the Hip Disability and Osteoarthritis Outcome Score(HOOS)
Time Frame: at finish f/u survey by June 2021
HOOS is developed as an instrument to assess the patients' opinion about their hip and associated problems. HOOS consists of 5 subscales; Pain, other Symptoms, Function in dailyliving (ADL). Standardized answer options are given and each question gets a score from 0 to 4. A normalized score(100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale. The result can be plotted as an outcome profile. We will conduct an validated Korean HOOS questionnaire.(to hip joint , ilium, ischium, and pubis fracture)
at finish f/u survey by June 2021
the Foot Function Index (FFI)
Time Frame: at finish f/u survey by June 2021
The FFI was developed to measure the effect of foot problems on function in terms of pain and disability. The FFI is a self-administered index consisting of 23 items divided into 3 scales(limitation, pain, and disability). Korean FFI questionnaire was validated in only 2 scales(pain, disability), and we use only pain scale of FFI (to ankle and foot fracture).
at finish f/u survey by June 2021
Symptoms of RIB,STERNUM fracture
Time Frame: at finish f/u survey by June 2021
There is no validated worldwide used questionnaire. so we use 4 questions about symptoms associated with rib and sternum fracture, based on previous article. (pain during deep breathing, coughing, turning over the body, and sleeping)
at finish f/u survey by June 2021
Patient Global Impression of Change (PGIC)
Time Frame: at finish f/u survey by June 2021
PGIC is an indicator that evaluates the improvement of patients in 7 steps, and the subject responds with improvement of functional limitation after treatment with 7 likert. (1=very much improved, 2=much improved, 3=minimally improved, 4=no change, 5=minimally worse, 6=much worse, 7=very much worse).
at finish f/u survey by June 2021
hanbangchilyo manjogdo (Satisfaction with integrative Korean medicine)
Time Frame: at finish f/u survey by June 2021
5 answer options are given: very satisfied, a little satisfied, moderate, a little dissatisfied, very dissatisfied
at finish f/u survey by June 2021

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 29, 2021

Primary Completion (ACTUAL)

August 31, 2021

Study Completion (ACTUAL)

December 31, 2021

Study Registration Dates

First Submitted

April 12, 2021

First Submitted That Met QC Criteria

April 21, 2021

First Posted (ACTUAL)

April 22, 2021

Study Record Updates

Last Update Posted (ACTUAL)

February 8, 2022

Last Update Submitted That Met QC Criteria

January 25, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • JS-CT-2020-15

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fractures, Bone

Clinical Trials on online survey(or phone survey)

3
Subscribe